|
|
|
|
Дата |
|---|
| 12.01.2026 |
| 11.01.2026 |
| 08.01.2026 |
| 06.01.2026 |
| 05.01.2026 |
| 04.01.2026 |
| 01.01.2026 |
| 31.12.2025 |
| 30.12.2025 |
| 29.12.2025 |
Bid | Ask |
Open |
Min | Max |
Last |
Legal close |
Avg |
Оборот |
Кол-во сделок |
|---|---|---|---|---|---|---|---|
|
|
|
80.97
|
78.55
|
81.73
|
79.00
|
|
|
49 527 581.89
|
718.00
|
|
|
|
80.00
|
80.50
|
82.00
|
80.97
|
|
|
35 496 033.98
|
632.00
|
|
|
|
78.98
|
79.20
|
81.20
|
80.00
|
|
|
58 636 632.82
|
920.00
|
|
|
|
78.04
|
78.04
|
79.01
|
78.98
|
|
|
38 935 042.42
|
347.00
|
|
|
|
77.90
|
77.20
|
80.00
|
78.04
|
|
|
34 663 220.23
|
682.00
|
|
|
|
77.50
|
77.50
|
79.75
|
77.90
|
|
|
6 434 452.97
|
429.00
|
|
|
|
78.00
|
77.50
|
79.00
|
77.50
|
|
|
16 728 426.29
|
457.00
|
|
|
|
78.00
|
77.50
|
79.00
|
77.50
|
|
|
16 728 426.29
|
457.00
|
|
|
|
78.65
|
78.00
|
80.85
|
78.00
|
|
|
25 663 410.86
|
915.00
|
|
|
|
76.23
|
76.97
|
80.00
|
78.65
|
|
|
64 991 819.07
|
1 245.00
|
Период |
|---|
| 2022, регулярные |
| 2020, регулярные |
| 2018, регулярные |
| 2017, регулярные |
| 2016, регулярные |
| 2015, регулярные |
| 2012, регулярные |
| 2011, регулярные |
| 2010, регулярные |
|
Экс-дивидендная дата
|
Закрытие реестра |
Сумма выплаты |
|---|---|---|
|
13.04.2023
|
18.04.2023 |
2 EGP |
|
21.04.2021
|
25.04.2021 |
2.95 EGP |
|
02.05.2019
|
05.05.2019 |
4 EGP |
|
06.04.2018
|
10.04.2018 |
4.5 EGP |
|
08.05.2017
|
09.05.2017 |
3.5 EGP |
|
21.04.2016
|
24.04.2016 |
3.5 EGP |
|
23.04.2013
|
24.04.2013 |
3 EGP |
|
24.05.2012
|
27.05.2012 |
3 EGP |
|
29.04.2011
|
02.05.2011 |
2.5 EGP |
Egyptian International Pharmaceuticals Industries Co SAE (EIPICO) is an Egypt-based public shareholding company that operates in the pharmaceuticals industry. The Company is a manufacturer and exporter of pharmaceuticals, and holds license agreements with a group of international pharmaceutical companies to produce their products locally and replace the imported ones. The Company produces dosage forms, such as spansule capsules (long-acting), as well as non-traditional dosage forms, such as the soft gelatin capsules, lyophilized products, gels, sprayers and effervescent tablets
